AzTrials
AzTrials

Symptomatic Gallbladder StonesPhase 2/3NCT00904865

Single Port Access (SPA) Cholecystectomy Versus Standard Laparoscopic Cholecystectomy

A Phase 2/3 study testing SPA cholecystectomy and Laparoscopic cholecystectomy in people with Symptomatic Gallbladder Stones and Cholecystitis, run by University Hospital, Geneva at 1 site in Switzerland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background: Single port access surgery is a rapidly progressing surgical approach which allows performance of standard laparoscopic surgery through a single transparietal port instead of multiple port accesses. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
SPA cholecystectomy and Laparoscopic cholecystectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteSwitzerland
Study dates
Feb 2009to Feb 2011
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age more than 18 years

Who cannot join

  • Contraindication to laparoscopy
  • Liver disease
  • Cognitive trouble

Trial locations and contacts

1 site in 1 country.

Switzerland1 site, 1 recruiting
  • University Hospital Geneva

    Geneva, Canton of Geneva, 1211

    Pascal Bucher, MD, ¦41223723311 ext. 7958420, pascal.bucher@hcuge.ch

    Pascal Bucher, MD

    Recruiting

Other trials in Switzerland

About this study

Official title: Single Port Access Cholecystectomy Versus Standard Laparoscopic Cholecystectomy - Randomized Study

Background:

Single port access surgery is a rapidly progressing surgical approach which allows performance of standard laparoscopic surgery through a single transparietal port instead of multiple port accesses.

Read more

Objective:

Demonstrate the validity of Single port access (SPA) cholecystectomy compared to multiple ports laparoscopic cholecystectomy.

Hypothesis:

SPA cholecystectomy is associated with decreased parietal and body image trauma compare to multiple ports laparoscopic cholecystectomy. SPA cholecystectomy should be associated with better cosmetic results, may improve postoperative recovery due to lower parietal pain. SPA cholecystectomy may also be associated with decreased rate of parietal complications as lower numbers of transparietal port are placed.

Methods:

All patients offered cholecystectomy, either SPA or multiport cholecystectomy, included in the study will have recognized biliary pathology for which formal indication cholecystectomy are recognized internationally.

Surgical technique, either for SPA cholecystectomy or for multiple ports cholecystectomy, will be the same except, that one surgical technique is achieved through a single transparietal port and the other through multiple ports.

Randomization will be performed before surgeries after patients have given their informed consent to the study.

No specific test or cost will be necessitated by the study. Patients will be informed orally and will receive a short study summary, allowing them to give an informed consent.

Endpoints:

  • Morbidity
  • Body image and Cosmetic results
  • Post-operative pain (opioid sparing effect)
  • Operative time
  • Hospital stay
Being tested
SPA cholecystectomy, Laparoscopic cholecystectomy
Keywords
Single port access, Laparoscopy, cholecystectomy, cholangiography, cosmesis
Medical subject headings
Cholecystitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SPA cholecystectomyProcedure or surgery

    SPA cholecystectomy

  • Laparoscopic cholecystectomyProcedure or surgery

    Laparoscopic cholecystectomy

Study groups in NCT00904865
Study groupRoleWhat they receive
1OtherSPA cholecystectomy
Receives: Procedure: SPA cholecystectomy
2Otherlaparoscopic cholecystectomy
Receives: Procedure: Laparoscopic cholecystectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cosmesis, body image and quality of life scale

    Measured: at 1 month

Secondary outcomes (3)
  1. Post-operative morbidity

    Measured: at 30 days

  2. Post-operative pain

    Measured: 10 days

  3. Operative time

    Measured: day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2009 (estimated)
  2. Study startFeb 2009
  3. Primary completionFeb 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00904865
Sponsor's protocol ID
CER-08-145
Status last verified
May 2009
First submitted
19 May 2009
Last updated
20 May 2009
Results posted
No
Data monitoring committee
No

Publications

  • Bucher P, Pugin F, Buchs N, Ostermann S, Charara F, Morel P. Single port access laparoscopic cholecystectomy (with video). World J Surg. 2009 May;33(5):1015-9. doi: 10.1007/s00268-008-9874-4.

    PubMed 19116734
  • Bucher P, Pugin F, Buchs NC, Ostermann S, Morel P. Randomized clinical trial of laparoendoscopic single-site versus conventional laparoscopic cholecystectomy. Br J Surg. 2011 Dec;98(12):1695-702. doi: 10.1002/bjs.7689. Epub 2011 Sep 30.

    PubMed 21964736
  • Steinemann DC, Raptis DA, Lurje G, Oberkofler CE, Wyss R, Zehnder A, Lesurtel M, Vonlanthen R, Clavien PA, Breitenstein S. Cosmesis and body image after single-port laparoscopic or conventional laparoscopic cholecystectomy: a multicenter double blinded randomised controlled trial (SPOCC-trial). BMC Surg. 2011 Sep 12;11:24. doi: 10.1186/1471-2482-11-24.

    PubMed 21910897

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing SPA cholecystectomy and Laparoscopic cholecystectomy in people with Symptomatic Gallbladder Stones and Cholecystitis, run by University Hospital, Geneva at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 May 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pascal Bucher, MD (+41223723311 ext. 7958420, pascal.bucher@hcuge.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cosmesis, body image and quality of life scale (time frame: at 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00904865, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in